GLP-1 users’ malnutrition and muscle-loss risks remain untracked, experts warn
A University of Newcastle review assessed diet studies covering about 50,000 adults taking GLP-1 drugs. Experts said the extent of malnutrition and muscle loss among users was not being tracked.
Nutrition experts warned some Australians using GLP-1 drugs could face malnutrition and muscle loss. Newcastle research found a gap in evidence on rapid weight loss and GLP-1 health risks, the article said.1
Collins’ review assessed studies of diets in about 50,000 adults taking the drugs, the article reported. Collins said sharply reduced food intake could leave users short of protein needed to protect muscle.1
The article reported that fatigue and nausea could be missed because they resembled some nutrient-deficiency symptoms. Guidance cited in the article included strength training to preserve muscle and bone density.1
